Allogene Therapeutics: redefining the future of CAR-T

Allogene Therapeutics
Biopharma Dealmakers · Springer Nature · 2025-12-01 · DOI: 10.1038/d43747-025-00108-z

Abstract

Biopharma Dealmakers, Published online: 01 December 2025; doi:10.1038/d43747-025-00108-z The biotech is aiming to develop a first-line consolidation treatment for large B-cell lymphoma that predicts and prevents relapse.

Read at publisher →

Similar articles